Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients

This study has been completed.

Study NCT00795418 Information provided by Novartis

First Received: November 10, 2008 Last Updated: December 16, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	November 2010 (Final data collection date for primary outcome measure)